Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound)
3 The takeaway: Behavior change matters to people on GLP-1s, and the Noom app continues to be associated with stronger real-world GLP-1 outcomes Taken together, these findings tell a clear story: people who pair GLP-1 medication with consistent engagement in the Noom app see more success at weight loss, and, independently, they stay with the program longer
Keep in mind, however, that managing blood pressure is complex and continues to be influenced by other important lifestyle factors like diet, exercise, and stress
Curabitur pharetra, neque a vestibulum pharetra, tortor leo porttitor nisl, vitae bibendum elit ligula eget felis
Patches genuinely appeal to buyers who don't want to swallow capsules daily, who want a set-it-and-forget-it application routine, or who have GI sensitivities that make oral supplements uncomfortable
Quality indicators beyond color Color is one quality indicator, but not the only one